286 investors have funded 94 Life Sciences companies head-officed in Shenzhen, across 424 rounds (Jun 2012 – Apr 2026). They are ranked by how many Shenzhen companies in this market they have actually backed.
"In Shenzhen" describes the companies, not the investor: most of the money in any city comes from somewhere else, and the Where the money comes from section below shows exactly where it came from here.
Ranked by companies backed in this market and city, then by round count. "Led" counts rounds recorded with this investor as lead.
| # | Investor | Based in | Stages here | Companies | Rounds | Led | Latest | Portfolio total |
|---|---|---|---|---|---|---|---|---|
| 1 | Shenzhen Capital Group | Shenzhen, China | Series BSeedSeries A | 8 | 11 | 5 | May 2025 | 372 |
| 2 | Shenzhen Gaoxintou Group | Shenzhen, China | Series BSeries AAngel | 6 | 7 | — | Aug 2023 | 60 |
| 3 | Qiming Venture Partners | Shanghai, China | Series BSeries CSeed | 5 | 9 | 2 | Nov 2025 | 337 |
| 4 | CDH | Kowloon, China | SeedSeries BAngel | 5 | 6 | 5 | Mar 2026 | 224 |
| 5 | Efung Capital | Shenzhen, China | Series CSeedAngel | 5 | 6 | 4 | Aug 2025 | 34 |
| 6 | Cowin Capital | Shenzhen, China | Series BSeries A | 4 | 4 | 2 | Jul 2023 | 184 |
| 7 | Vinno Capital | Shenzhen, China | Series ASeedAngel | 4 | 4 | 2 | Jan 2023 | 19 |
| 8 | Sequoia Capital China | Beijing | Series CSeries BSeries A | 3 | 6 | 3 | Jan 2022 | 345 |
| 9 | Legend Capital | Haidian, China | Series BSeries A | 3 | 5 | 3 | Feb 2023 | 335 |
| 10 | Leaguer Group | Shenzhen, China | SeedAngelSeries A | 3 | 4 | 3 | Jul 2023 | 31 |
| 11 | Alwin Capital | SeedSeries ASeries B | 3 | 4 | 2 | Jun 2023 | 15 | |
| 12 | Sequoia Capital | Menlo Park, United States | Series BSeries C | 3 | 3 | 3 | Nov 2021 | 1,568 |
| 13 | Orbimed | New York City, United States | Series C | 3 | 3 | — | Nov 2021 | 422 |
| 14 | Lenovo | Hong Kong, China | Series ASeedSeries C | 3 | 3 | 2 | Jul 2023 | 85 |
| 15 | SDIC | Beijing, China | Series BPost-IPO | 3 | 3 | 1 | Jun 2022 | 91 |
| 16 | Yuanbio Venture Capital | Suzhou, China | Series A | 3 | 3 | 1 | Nov 2021 | 79 |
| 17 | CICC Capital | Series BSeries C | 3 | 3 | 2 | Feb 2022 | 85 | |
| 18 | Qianhai Ark Asset Management | Shenzhen, China | Series CSeries A | 3 | 3 | 3 | Dec 2023 | 76 |
| 19 | Greater Bay Area Homeland Investments | Hong Kong, China | Series C | 3 | 3 | 2 | Nov 2021 | 35 |
| 20 | ASB Ventures | Shenzhen, China | Series BSeries ASeed | 3 | 3 | 2 | May 2021 | 9 |
| 21 | Gaorong Capital | Beijing, China | Series BSeries ASeries D | 2 | 6 | 3 | Nov 2025 | 203 |
| 22 | 5Y Capital | Shanghai, China | Series BSeries A | 2 | 6 | 1 | Jun 2022 | 154 |
| 23 | SBCVC | Shanghai, China | Series ASeries D | 2 | 4 | 2 | Jul 2022 | 113 |
| 24 | Long Hill Capital | Shanghai, China | SeedSeries AAngel | 2 | 4 | 1 | Jun 2023 | 24 |
| 25 | Eight Roads Ventures | London, United Kingdom | Series ASeries B | 2 | 3 | 1 | Feb 2024 | 333 |
| 26 | Hillhouse | New York City, United States | Series BSeries C | 2 | 3 | — | Dec 2020 | 341 |
| 27 | Puhua Capital | Hangzhou, China | SeedSeries BSeries A | 2 | 3 | 1 | Jun 2021 | 120 |
| 28 | Beijing Fangyuan Jinding Investment Management | Beijing, China | SeedSeries A | 2 | 3 | 3 | Jul 2023 | 42 |
| 29 | IDG Capital | New York City, United States | Series B | 2 | 2 | 2 | May 2020 | 636 |
| 30 | Shunwei Capital | Beijing, China | AngelSeed | 2 | 2 | 1 | Feb 2023 | 339 |
| 31 | Oriental Fortune Capital | Shenzhen, China | Series A | 2 | 2 | 1 | May 2023 | 169 |
| 32 | Green Pine Capital Partners | Beijing, China | Series BSeries D | 2 | 2 | 1 | Dec 2022 | 127 |
| 33 | Tiantu Capital | Shenzhen | Series BSeed | 2 | 2 | 1 | Jun 2022 | 75 |
| 34 | China Merchants Capital | Shenzhen, China | Series C | 2 | 2 | — | Dec 2020 | 80 |
| 35 | HSG | Hong Kong, China | AngelSeed | 2 | 2 | 2 | Mar 2026 | 61 |
| 36 | Loayal Valley Capital | Shanghai, China | Series CSeries A | 2 | 2 | 1 | Nov 2025 | 52 |
| 37 | CPE | Beijing, China | Series B | 2 | 2 | 1 | Mar 2022 | 53 |
| 38 | Shenzhen Guozhong Venture Capital Management | Shenzhen, China | Series A | 2 | 2 | 1 | Oct 2021 | 49 |
| 39 | Share Capital | Shenzhen, China | Series A | 2 | 2 | 1 | Oct 2021 | 47 |
| 40 | Octagon Capital Advisors | New York City, United States | Series C | 2 | 2 | — | Nov 2021 | 30 |
| 41 | Shanghai Healthcare Capital | Shanghai, China | Series DSeries B | 2 | 2 | 1 | Dec 2022 | 18 |
| 42 | Shenzhen Leaguer | Shenzhen, China | Series CSeries A | 2 | 2 | 1 | Dec 2022 | 19 |
| 43 | Zijingang Capital | Shenzhen, China | Series ASeed | 2 | 2 | 2 | Jan 2024 | 13 |
| 44 | CBC Group | New York City, United States | Series BSeed | 2 | 2 | 1 | Jun 2022 | 14 |
| 45 | Shenzhen Nanshan Strategic Emerging Industries Investment | Shenzhen, China | Series ASeed | 2 | 2 | 1 | Nov 2025 | 13 |
| 46 | LanTing Capital | Saanen, Switzerland | Series C | 2 | 2 | — | Dec 2020 | 10 |
| 47 | FUHO Capital Management | Haidian, China | Series ASeed | 2 | 2 | 2 | Nov 2024 | 8 |
| 48 | Huada Gene | Shenzhen, China | Series BSeed | 2 | 2 | — | Mar 2018 | 5 |
| 49 | K2VC | Beijing, China | Series CSeries B | 1 | 3 | 1 | Jan 2025 | 250 |
| 50 | 3H Health Investment | Hong Kong, China | Series ASeries BSeries C | 1 | 3 | — | Nov 2021 | 17 |
| 51 | Changan Private Capital | Xicheng, China | SeedAngel | 1 | 3 | 1 | Jun 2023 | 17 |
| 52 | Lilly Asia Ventures | Shanghai | Series BSeries C | 1 | 2 | 1 | Jul 2023 | 104 |
| 53 | Yonghua Capital | Shanghai, China | Series A | 1 | 2 | 1 | Jan 2019 | 95 |
| 54 | DHVC | Palo Alto, United States | Seed | 1 | 2 | 2 | Mar 2018 | 83 |
| 55 | Meituan | Beijing, China | Series BSeries C | 1 | 2 | 1 | Jul 2023 | 54 |
| 56 | Primavera | Beijing, China | Series B | 1 | 2 | 1 | Dec 2021 | 61 |
| 57 | LYFE Capital | Menlo Park, United States | Series BSeries C | 1 | 2 | 1 | Nov 2021 | 40 |
| 58 | IMO Ventures | San Mateo, United States | SeedSeries A | 1 | 2 | 1 | Feb 2025 | 25 |
| 59 | Guiyang Venture Capital | Guiyang, China | Series CSeries A | 1 | 2 | — | Apr 2021 | 25 |
| 60 | Edge ventures | Shanghai, China | Seed | 1 | 2 | — | May 2018 | 23 |
| 61 | Sherpa Venture Capital | Beijing, China | Series B | 1 | 2 | — | Apr 2020 | 16 |
| 62 | Triwise Capital | Shenzhen, China | Series A | 1 | 2 | 1 | Jan 2019 | 12 |
| 63 | New World Development | Hong Kong, China | Series BSeries C | 1 | 2 | 1 | Jul 2023 | 11 |
| 64 | Tianfeng Capital | Beijing, China | Series A | 1 | 2 | — | Nov 2025 | 4 |
| 65 | Vcanbio Cell & Gene Engineering Corporation | Tianjin, China | Series A | 1 | 2 | 1 | Apr 2016 | 2 |
| 66 | Sansure | Changsha, China | Series B | 1 | 2 | 1 | Sep 2021 | 1 |
| 67 | Tencent | Shenzhen, China | Series A | 1 | 1 | 1 | Apr 2016 | 685 |
| 68 | Temasek | Singapore, Singapore | Series C | 1 | 1 | 1 | Nov 2021 | 450 |
| 69 | SOSV | Cork, Ireland | Seed | 1 | 1 | 1 | Mar 2019 | 446 |
| 70 | Zhen Fund | Beijing, China | Series A | 1 | 1 | 1 | Aug 2018 | 412 |
| 71 | Gobi Partners | Kuala Lumpur, Malaysia | Series A | 1 | 1 | 1 | Jul 2014 | 214 |
| 72 | BlueRun Ventures | Menlo Park, United States | Seed | 1 | 1 | — | Mar 2026 | 156 |
| 73 | EQT | Stockholm, Sweden | Series C | 1 | 1 | 1 | Jan 2025 | 205 |
| 74 | Xiaomi | Beijing, China | Seed | 1 | 1 | — | Dec 2021 | 185 |
| 75 | Fortune Capital | Shenzhen, China | Series A | 1 | 1 | — | Sep 2018 | 191 |
| 76 | CICC | Beijing, China | Series C | 1 | 1 | — | Jan 2020 | 171 |
| 77 | Yuanhe Holdings | Suzhou, China | Angel | 1 | 1 | — | 130 | |
| 78 | Mirae Asset | Seoul, South Korea | Series C | 1 | 1 | — | Nov 2021 | 133 |
| 79 | Lanchi Venture Capital | Chaoyang, China | Angel | 1 | 1 | 1 | Feb 2023 | 96 |
| 80 | Yunfeng Capital | Shanghai, China | Series B | 1 | 1 | 1 | Jun 2022 | 118 |
| 81 | Legend Star | Beijing, China | Series A | 1 | 1 | 1 | Apr 2020 | 104 |
| 82 | Ant Group | Hangzhou, China | Seed | 1 | 1 | — | Mar 2026 | 110 |
| 83 | Baidu Ventures | Series A | 1 | 1 | 1 | Jan 2022 | 100 | |
| 84 | JD.com | Beijing, China | Series B | 1 | 1 | 1 | Jul 2015 | 103 |
| 85 | Qingsong Fund | Shenzhen, China | Seed | 1 | 1 | — | Dec 2021 | 99 |
| 86 | Alpha JWC Ventures | Jakarta, Indonesia | Series C | 1 | 1 | — | Jan 2025 | 78 |
| 87 | Huagai Capital | Dongguan, China | Series B | 1 | 1 | 1 | Jun 2020 | 98 |
| 88 | Aplus Capital | Haidian, China | Series A | 1 | 1 | 1 | Sep 2020 | 97 |
| 89 | CoStone Capital | Shenzhen, China | Series B | 1 | 1 | 1 | May 2020 | 87 |
| 90 | CMB International Capital | Hong Kong, China | Series A | 1 | 1 | 1 | Mar 2021 | 78 |
| 91 | Vertex Ventures | Beijing, China | Series B | 1 | 1 | — | Jan 2021 | 68 |
| 92 | Ping An Ventures | Pudong, China | Series C | 1 | 1 | — | Jan 2020 | 74 |
| 93 | Medtronic | Minneapolis, United States | PE | 1 | 1 | — | Oct 2012 | 56 |
| 94 | Sky9 Capital | Shanghai, China | Series B | 1 | 1 | — | Dec 2021 | 68 |
| 95 | Decent Capital | Atherton, United States | Seed | 1 | 1 | 1 | Jun 2022 | 74 |
| 96 | MSA Capital | Chaoyang, China | Series A | 1 | 1 | 1 | Oct 2021 | 66 |
| 97 | Volcanics Venture | Shanghai, China | Series A | 1 | 1 | — | Jan 2022 | 58 |
| 98 | Boyu Capital | Hong Kong, China | Series C | 1 | 1 | 1 | Nov 2021 | 66 |
| 99 | China Renaissance Group | Chaoyang, China | Series B | 1 | 1 | 1 | Mar 2022 | 61 |
| 100 | TusStar | Beijing, China | Angel | 1 | 1 | — | Nov 2022 | 57 |
Showing the top 100 of 286. Search the full investor set →
Head office of the investors on this page.
Rounds by stage — where in a company's life this money arrives.
Total disclosed size of each round, not one investor's share.
How active this market has been.
Life Sciences companies head-officed in Shenzhen that took money from these investors.
| Company | Backers | Rounds | Disclosed | Latest round |
|---|---|---|---|---|
| Shenzhen Jingfeng Medical Technology edgemed.cn |
18 | 21 | $2.9B | Series C Nov 2021 |
| Cornerstone Robotics csrbtx.com |
18 | 27 | $2.7B | Series D Nov 2025 |
| InnerMedical innermed.com |
16 | 19 | $61.8M | Series D Dec 2022 |
| Immvira immvira-theravir.com |
13 | 15 | $302M | Series C Dec 2020 |
| MGI mgi-tech.com |
11 | 11 | $11B | Series B May 2020 |
| Shenzhen Core Medical Technology coretechmed.com |
10 | 11 | $29M | Series C Apr 2023 |
| ImmVira immviragroup.com |
10 | 11 | $20M | Series C Oct 2022 |
| Xbiome xbiome.com |
9 | 18 | $722.5M | Series B Dec 2021 |
| Leman Biotech lemanbio.com |
9 | 9 | $215.9M | Series A Mar 2026 |
| Insight Lifetech insight-med.com |
9 | 12 | $198.2M | Series C Dec 2020 |
| Moda Bio metabiopharma.com |
9 | 10 | — | Series A Feb 2025 |
| Vivolight vivolight.com |
8 | 8 | $86.9M | Seed Mar 2026 |
| Axbio axbio.cn |
7 | 8 | $800M | Series B Jun 2022 |
| Silicon-based sibionics.com |
7 | 7 | $516M | Series D Dec 2022 |
| Eartech eartech.cn |
7 | 7 | — | Seed Aug 2022 |
| ICarbonX icarbonx.com |
6 | 7 | $671.4M | Series D Apr 2021 |
| China Resources Bio-Pharmaceutic crbiopharm.com |
6 | 6 | $531.2M | Series B Jan 2023 |
| Innorna innorna.com |
6 | 6 | $360M | Series B Mar 2022 |
| Aibo Medical abrobo.com |
6 | 12 | $159.8M | Seed Jun 2023 |
| Haplox haplox.cn |
6 | 8 | $103.5M | Series D Jul 2022 |
| Salus salus-bio.com |
6 | 7 | — | Series A May 2025 |
| GeneMind genemind.com |
5 | 6 | $333M | Series C Aug 2023 |
| Shenzhen Shenyan Biotechnology eurekabio.com |
5 | 6 | $223.5M | Series B Feb 2024 |
| Yuanhua Intelligent Technology yuanhuatech.com |
5 | 7 | $150M | Series B Jan 2022 |
| Shenzhen Target tjrbiosciences.com |
5 | 6 | $99.5M | Series A Sep 2020 |
| Pulsecare Medical Technology pulsecare.cn |
5 | 6 | $56.1M | Series A Nov 2025 |
| Aegicare aegicare.com |
5 | 6 | $50.2M | Series B Dec 2020 |
| Milebot milebot.com.cn |
5 | 5 | — | Series A Feb 2022 |
| Biocomma biocomma.com |
4 | 4 | $61.8M | Series A Nov 2021 |
| Dap Biotechnology dapbiotechnology.vdtrxn |
4 | 4 | $55.4M | Series B Jan 2024 |
| Sleepace sleepace.com |
4 | 4 | $24.5M | Series B Jun 2017 |
| Proxinse proxinse.com |
4 | 4 | — | Series A Oct 2022 |
| Shenzhen Enduring Biotech shenzhenenduring.com |
4 | 4 | — | Series A Oct 2021 |
| HugeMed hugemed.net |
4 | 4 | — | Series C Mar 2026 |
| Shenzhen Zifu Medical Technology jifu-tech.com |
4 | 4 | — | Series C Sep 2020 |
| Artivila Therapeutics artivila.com |
3 | 3 | $68.5M | Seed Mar 2021 |
| Fuessen fussengroup.com |
3 | 3 | $43.1M | Series C Jan 2020 |
| Shenzhen Hannuo Medical Technology cbmed.cn |
3 | 3 | $42.1M | Series E+ Jan 2024 |
| Neoimmune neoimmune.cn |
3 | 3 | $9.4M | Seed Nov 2021 |
| Forward Pharma forward-pharm.com |
3 | 4 | $4.2M | Series A Jul 2023 |
| OxTium Technology oxtium.com |
3 | 3 | — | Seed Nov 2025 |
| Sophway Technology sophway.com |
3 | 3 | — | Angel Nov 2022 |
| WeGene wegene.com |
3 | 3 | — | Series B Jan 2018 |
| Yuce Biotechnology yucebio.com |
3 | 3 | — | Series B Dec 2018 |
| Shenzhen Weiling Medical Equipment Co shenzhenweilingmedicalequipment.vdtrxn |
3 | 3 | — | Angel Feb 2023 |
| Fussen Technology fussen.dental360.cn |
3 | 3 | — | Series C Jan 2020 |
| Anke anke.com |
3 | 3 | — | Series B Nov 2020 |
| Shenzhen Kangtai Biological Products biokangtai.com |
3 | 3 | — | Series A Jan 2022 |
| LONGLIGHT longlightech.com |
3 | 3 | — | Seed Oct 2024 |
| Gene Biotechnology genocury.com |
3 | 3 | — | Angel Jan 2023 |
| Date | Investor | Company | Stage | Round size |
|---|---|---|---|---|
| Apr 2026 | FountainBridge CapitalLED | Polyncure | Seed | — |
| Mar 2026 | C&D | HugeMed | Series C | — |
| Mar 2026 | Sunshine Insurance Group | HugeMed | Series C | — |
| Mar 2026 | Harvest CapitalLED | HugeMed | Series C | — |
| Mar 2026 | Fuhui Venture Capital | Leman Biotech | Series A | $29M |
| Mar 2026 | Zhongshan Venture Capital | Leman Biotech | Series A | $29M |
| Mar 2026 | Tailong Investment | Leman Biotech | Series A | $29M |
| Mar 2026 | Zhongying Venture Capital | Leman Biotech | Series A | $29M |
| Mar 2026 | Mining World Star | Leman Biotech | Series A | $29M |
| Mar 2026 | Mony Valley | Leman Biotech | Series A | $29M |
| Mar 2026 | Ant Group | Vivolight | Seed | $14.5M |
| Mar 2026 | Jiuhe Advanced Science and Technology | Vivolight | Seed | $14.5M |
| Mar 2026 | BlueRun Ventures | Vivolight | Seed | $14.5M |
| Mar 2026 | CDH | Vivolight | Seed | $14.5M |
| Mar 2026 | HSGLED | Vivolight | Seed | $14.5M |
| Mar 2026 | Anyu Capital | Vivolight | Seed | $14.5M |
| Nov 2025 | Shenzhen Nanshan Strategic Emerging Industries Investment | OxTium Technology | Seed | — |
| Nov 2025 | Qiming Venture Partners | Cornerstone Robotics | Series D | $200M |
| Nov 2025 | Hong Kong Investment Corporation LimitedLED | Cornerstone Robotics | Series D | $200M |
| Nov 2025 | Gaorong Capital | Cornerstone Robotics | Series D | $200M |
Life Sciences investors in other cities
Other markets in Shenzhen